Get Flat 10% Discount on Anti-Parkinson Medication
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
    • Just look at what our Tens of Thousands of Satisfied Customers say about us
    Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    International Pharma Industry News
    You are here: Home > Pharmacy News | Health Articles/Tips > International Pharma Industry News

    Latest News - International Pharma Industry News

      39 New Drug Approvals by US FDA in 2012, Hit A 16-Year High

      The US Food and Drug Administration (US FDA) approved a record number of 39 new drugs in 2012, marking the highest in 16 years. When compared with 39 approvals in 2012, only 30 new drugs were approved in 2011 and just 21 in 2010. In December alone, the FDA approved 8 new ...READ MORE>>
      January 07, 2013
    News Archives - 2013
    39 New Drug Approvals by US FDA in 2012, Hit A 16-Year High
    News Archives - 2012
    US FDA Approves Teva's Chronic Myelogenous Leukemia Drug, Synribo
    Strides Arcolab Gets USFDA Nod to Sell Cancer Drug in US
    Attention Deficit Hyperactivity Disorder Drugs in Short Supply, reports FDA
    News Archives - 2011
    FDA Approves Merck’s New Drug Victrelis For Treatment Of Hepatitis C
    Mylan Pharma rolls out muscle relaxant drug
    FDA OKs New Diabetes Pill From Boehringer, Lilly
    Adventrx Pharma Acquiring SynthRx
    Merck gets FDA nod for skin cancer drug
    Watson Pharma Applies To Make Generic Vigamox
    Fake Chinese drugs with 'made in India' labels continue to hit African markets, says Nigerian FDA chief
    FDA panel backs NovoCure's cancer treatment device
    Aratana Therapeutics buys health product licenses from RaQualia Pharma
    Impax gets FDA approval for antibiotic
    Sanofi-Aventis, International Vaccine Institute Partner
    Natco Pharma challenges patent on Tamiflu
    Neuralstem gets US FDA orphan drug status for spinal cord stem cells for ALS treatment
    Nestle buys UK-based CM&D Pharma
    AstraZeneca's Nasal Flu Vaccine Approved In Europe
    Lincoln Pharma gets patent approval for nasal spray treatment
    Abstral transmucosal tablets receives FDA approval to manage pain in cancer patients
    FDA Cancer Division Head Defends Avastin Decision
    News Archives - 2010
    Mylan receives US FDA approval for generic Adalat CC tablets
    Reckitt Benckiser to buy India's Paras Pharma
    Watson Pharma seeking India acquisitions: report
    Local Medicine Climbs Another Rung on FDA Ladder
    APP Pharmaceuticals to Launch Drug Hotline
    FDA Approves Botox for Migraine Prevention
    FDA Approves New Dosing for FASLODEXA
    FDA Approves New Use for Cymbalta: Chronic Musculoskeletal Pain
    Continuing drug shortages affect North American patients
    FDA approves Novartis drug for rare disease
    FDA approves Pradaxa to prevent stroke in people with atrial fibrillation
    Lorcaserin’s Path to Approval
    FDA may limit anemia drug use for kidney disease
    FDA OKs Drug to Treat Opioid Addiction
    Generic blood pressure drugs approved
    FDA reviewing safety of Actos diabetes drug
    Lipoxen's Ties With Baxter Strengthen After US$4 million Deal
    FDA approves abortion pill, ignores reality
    Santarus licenses approved diabetes drug for $5M
    F.D.A. Approves 5-Day Emergency Contraceptive
    Glenmark Generics gets USFDA approval for Norethindrone
    A second wave of generics opportunity
    News Archives - 2009
    Sanofi-aventis and Wellstat Therapeutics enter into an Exclusive Worldwide Licensing Agreement
    Schering-Plough Wins U.S. Approval for Antipsychotic
    The US FDA approves Lipsovir® for marketing and sales in US
    MDRNA gets FDA approval for Osteoporosis Nasal Spray
    Updated FDA, Clinical Trial Calendars: Myriad Pharma Announces Phase 1 Trial
    News Archives - 2008
    Japan's Daiichi in Ranbaxy deal
    Indian-American creates molecule that stops SARS virus
    Wockhardt launches midazolam injection in US
    Akorn-Strides, LLC Announces FDA Approval for Pamidronate Disodium Injection, 3 mg/mL and 9 mg/mL
    Just the right pill for pharma firms
    HHS Preparing to Open FDA Offices in China, India, Europe, and Latin America This Year
    Zevalin® Receives Positive CHMP Opinion in Europe for First-Line Consolidation Treatment
    Pfizer introduces anti-smoking drug 'Champix' in India
    Lilly loses appeal in U.K. drug case
    News Archives - 2006
    Pharma firms rush for in-licensing deals
    Cephalon settles mylan patent matter
    US drug cos file five patent claims with 'Aarogyapacha' as ingredient
    JB Chemicals enters into agreement with Taro Pharmaceutical industries
    McKinnell: 2 new Pfizer drugs are 'breakthroughs'
    Pharma companies can benefit from stem cell research: Expert
    Freight costs hit pharma firms
    Governments must fund pharma research to help poor: Laureate
    Set standards for these medicines
    News Archives - 2005
    Pharma policy draft for halving excise duty to 8 percent
    GSK India to Ally with Two More Japan Firms
    Glaxo plans to make Mumbai plant global hub
    Mankind Pharma targets Rs 1,000-cr turnover
    Cheers AltX, howzit main board for Enaleni
    Japan plans to invest $2b in India
    US pharma firm opens R & D Unit in Bangalore
    Pharma cos may get tax refund for donated drugs
    Drug delivery devices emerging as new business opportunity: Dr. Johnston
    7 Chemicals JV with South Africa to run PSU drug-manufacturing company, hospital
    Cadila to set up $2m centre in Colombo
    Eli Lilly eyes local tie-ups to pump funds into India
    Apollo to provide health cover to techies in US
    NPIL plans acquisition in UK, N. America
    US court rules against Ranbaxy, supports Pfizer patent
    GSK prepares to bring bird-flu drug to India
    Indonesian Pres seeks strategic partnership with India
    Nicholas Pirmal acquires Avecia Pharmacueitcals in UK
    Pfizer marks another win against generic drugs
    Glaxo starts development of new drugs and new test centers in India, South Asia
    Ernst & Young Showcases India, China's Strengths at New Jersey
    US OKs generic AIDS drug for children's use abroad
    Asian drug-makers ready to make generic versions of Tamiflu
    Piramal acquires UK-based pharma firm
    Holland to boost outsourcing to India
    AstraZeneca plans R&D tie-ups with Indian firms
    Cipla bird flu drug defies Roche
    India, Pakistan may grant easy visas for business
    Drug firms shrug off patent setbacks
    Global drug firms now want backdoor patent for generics
    Bangladeshi pharma draws comparison with Ranbaxy
    India: Prescription for growth
    IT, drug firms press for data security norms
    New York Life Investment to pump in $100 million in India
    Pfizer wins court challenge on Lipitor
    Pfizer to ramp up R&D in India
    U.S. drug standard co. plans India hub
    Drug price control order
    MNCs favour India, China as R&D destinations
    Govt may step in to curb Indian pharma war in Africa
    South Africa's Aspen, India's Lupin in TB drugs
    Aspen Pharmacare, Matrix to set up venture
    Japan-Based Nidek to Strengthen Opthalmic Business in India
    Forge stronger ties with Britain
    Elder Pharma ties up with Swiss major TRB Chem
    Japanese drug firm Eisai sets up Indian operations
    Two new Indo-British Initiatives in Pharmaceuticals
    ICICI Venture buys Ranbaxy chemicals biz
    President Barroso to attend EU-India summit in New Delhi on 7 September
    Cost-effective R&D outsourcing attracts Global Pharmaceutical industry to India and China
    Expert panel for de-branding of some drugs
    India: Vietnam looking for Indian investment to complete
    US envoy for corporate approach to combat
    Manufacturers prefer India to US in FDI stakes
    A New World Economy
    India, Pakistan talk trade
    USP comes to India, eyes Asia
    India, Pakistan begin talks on boosting bilateral trade
    Bush's bold new gamble
    India: Commerce Secretary calls for diversification in exports to China
    India, EU to further trade partnership
    US Firm offers $4 bn investment in UP